| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | 0% | 0% |
Lux Capital argues that concentration, not dilution, drives capitalist success across markets, capital, and power. The firm enters 2026 with $1.5 billion in new capital, managing $7 billion total, positioned for a landscape where five companies represent 30% of S&P 500 market cap and venture capital flows into fewer, larger deals. Key investment themes include AI infrastructure evolution from speculation to hardened capex exceeding $600 billion, defense spending potentially reaching 5% of GDP with $21.4 billion in sector venture investment, and biotechnology emerging from cyclical winter with 35% XBI gains and reopening IPO windows. The firm anticipates a cultural shift from software to physical assets, evidenced by the Landman zeitgeist replacing The Social Network mentality. Geopolitical tensions drive defense technology demand, while biotech faces reduced public R&D funding creating private investment premiums. Portfolio companies Databricks, Ramp, and Anduril trade at secondary market premiums ahead of expected IPOs. Lux maintains concentrated conviction in matter that matters, rejecting dilutive diversification for focused bets on ambitious founders building physically constrained, capital-intensive businesses.
Concentration is capitalism's secret success and the dilution delusion must be ignored in favor of confident concentration in the ceaseless competition known as civilization, focusing on matter that matters in emerging frontiers where physical-world applications meet computational scale.
Confident concentration in the face of dilutive doubts, with focus on matter that matters behind the most ambitious people who turn this time is different into this time will be different. The next decade will favor capital-intensive, physically constrained businesses over software-based models.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Feb 21 2026 | 2025 Q4 | ANDURIL, DBRX, RAMP | AI, Biotechnology, Concentration, defense, energy, geopolitics, private markets, Venture Capital | - | Lux Capital champions concentration over dilution, managing $7 billion with $1.5 billion in fresh capital. The firm bets on AI infrastructure hardening, defense spending surge, and biotech revival while anticipating a cultural shift from software to physical assets. Portfolio companies trade at premiums with IPO expectations as venture capital concentrates into fewer, larger deals. |
| Nov 23 2025 | 2025 Q3 | 000660.KS, 005930.KS, ACN, AMZN, BA, CAP.PA, GOOGL, INTC, IT, LMT, META, MSFT, MU, NOC, NVDA, ORCL, RTX, TSLA | AI, Automation, Biotechnology, defense, geopolitics, Physical Sciences, semiconductors, Venture Capital | - | Lux Capital celebrates 25 years with over $1 billion distributed and positions for the next technology wave. AI's $400 billion capex boom creates opportunities in physical applications while defense modernization accelerates globally. Biotech offers decade-low valuations with decade-high technology quality. The firm targets technically complex ventures others find too difficult, focusing on physical, life, and computational sciences intersection. |
| Aug 20 2025 | 2025 Q2 | AAPL, AMZN, ASML, BTC-USD, CAT, GOOGL, GPRO, KKD, META, MSFT, NVDA, TSLA | AI, Biotechnology, defense, Friction Frontier, Robotics, semiconductors, Space, Venture Capital | - | Lux Capital invested $450M+ across 70+ companies in Q2 2025, targeting convergence opportunities at the Friction Frontier where computation meets physical constraints. Focus areas include AI verification bottlenecks, robotics foundation models, biotech enhancement rather than treatment, space payload cost reductions, and autonomous defense systems. Strategy emphasizes owning both physical bottlenecks and breakthrough solutions. |
| May 18 2025 | 2025 Q1 | NVDA, TSLA | AI, Biotechnology, defense, innovation, Partnerships, Space, technology, Venture Capital | - | Lux Capital champions partnerships as the engine of progress, focusing on human-machine collaboration across AI, defense, space, and biotechnology. The firm leverages strategic relationships with governments, corporates, and founders to build resilient networks that compound value over decades. Geopolitical shifts create opportunities for allied sci-tech diplomacy while requiring defensive positioning against export controls and trade tensions. |
| Feb 13 2025 | 2024 Q4 | AAPL, MTRP | AI, Biotechnology, China, defense, geopolitics, Open Source, Robotics, Space | - | Lux Capital backs breakthrough science companies achieving superlative results across AI, defense, biotech, space, and robotics. The firm positioned early for open-source AI dominance through Hugging Face and Together AI. Expects major capital shifts toward on-device inference and efficient chip architectures. Markets face elevated valuations and concentration risks, but portfolio companies represent science fiction becoming profitable reality. |
| Nov 23 2024 | 2024 Q3 | AAPL, GOOGL, META, MSFT, NVDA | AI, Biotechnology, defense, infrastructure, Robotics, semiconductors, technology, Venture Capital | - | Lux Capital focuses on extensionalism — investing in breakthrough technologies that transcend human limits. Their $191 million eGenesis investment achieved landmark xenotransplantation success. AI faces infrastructure bottlenecks shifting to power constraints. The venture ecosystem suffers historic liquidity drought with distributions at 2008 crisis levels. Rising capital costs favor efficiency over scaling, creating opportunities for disciplined investors. |
| Aug 14 2024 | 2024 Q2 | AAPL, AMZN, GOOGL, META, MSFT | AI, Automation, Biotechnology, defense, Science, Space, Venture Capital | - | Lux Capital champions rebel scientists achieving sci-tech superiority across AI, defense, biotechnology, space, and automation. Early AI investments are appreciating while Lux Labs has created 20+ ventures including Varda's orbital manufacturing and Evolutionary Scale's protein engineering AI. Despite venture capital's unsustainable return expectations and geopolitical risks, the firm expects continued scientific progress to drive competitive advantages and human advancement. |
| Feb 21 2024 | 2023 Q4 | AAPL, ADBE, GOOGL, INTC, LLY, META, MSFT, NVO, SPOT | AI, Biotechnology, defense, Maintenance, Open Source, Resilience, technology, Venture Capital | - | Lux Capital champions maintenance over futurism, arguing venture capital overinvests in 10+ year horizons while neglecting current system upkeep. The firm focuses on AI, defense, and biotech companies that strengthen existing infrastructure rather than chase distant breakthroughs. Despite market concentration risks and elevated debt levels, Lux sees opportunities in open-source AI platforms, defense contractors, and AI-enabled drug discovery. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q4 |
AIAI has evolved from speculative mania into hardened infrastructure investment with hyperscalers spending over $600 billion ahead. Five AI companies are already worth more than every venture-backed IPO of the dot-com era combined. AI will flatten alpha to beta in public markets, eroding analytical edge while behavioral edge persists. |
Infrastructure Hyperscalers Capex Alpha Analytics |
DefenseTotal U.S. venture investments in aerospace and defense hit $21.4 billion in 2025 across over 300 deals, nearly doubling its prior peak. Domestic defense spending may climb to 5% of GDP. Lux has invested over $100 million in several Israeli defense companies and believes these will emerge as the next major defense primes. |
Aerospace Spending Venture Israel Primes | |
BiotechnologyThe XBI was up over 35% last year, M&A has reawakened, and an IPO window appears to be opening amid the thaw of another cyclical biotech winter. Biotech companies produced more than 70% of newly approved drugs in recent years, yet biotech investment as a share of overall private funding hit a 20-year low. |
IPO M&A Drugs Funding Winter | |
ConcentrationFive companies now represent roughly 30% of the S&P 500's market cap with the top 10 exceeding 40%. Concentration is capitalism's secret success, goading asset allocators to place heaviest bets on brightest prospects. The dilution delusion must be ignored in favor of confident concentration. |
Market Cap Capitalism Asset Allocation Dilution Competition | |
Private CreditDebt has now arrived at the AI capex party and even brought a plus-one in the form of off-balance-sheet funding structures. Debt is just dilution in disguise. Until recently, debt was mostly absent from tech capex, dampening risk and keeping things comparably sober. |
Debt Off-balance-sheet Tech Capex Risk | |
GeothermalThe zeitgeist is shifting from people who code bits to people who extract atoms. The next decade of wealth creation will look more like Landman than The Social Network: capital-intensive, physically constrained, and far more dependent on legal permitting and infrastructure access than genius coding. |
Energy Physical Infrastructure Permitting Capital-intensive | |
| 2025 Q3 |
AIAI hyperscalers are spending over $400 billion in capex pursuing compute supremacy. The AI boom is profoundly physical requiring gigawatts of power, thousands of tons of copper wiring, and teraliters of cooling water. AI is transitioning from communication AI to physical AI including robotics, biology, defense, and manufacturing applications. |
Hyperscalers Capex Physical AI Robotics Infrastructure |
DefenseDefense exemplifies the collision of hard tech, autonomy and moral calculus. The postwar West's defense supply chains splintered into subcontractors creating strategic vulnerability. Warfare is mutating with tanks dying to cheap quadcopters and unmanned systems fighting while AI compresses decision time from minutes to milliseconds. |
Supply Chain Autonomy Unmanned Systems Manufacturing Deterrence | |
BiotechnologyBiotech sits at a rare intersection with valuations at decade lows but technology quality at decade highs. AI lets startups do more with less using large models to underwrite biology and reach clinical milestones with less capital. The next US edge will be complexity in ventures so technically hard that only frontier builders attempt them. |
Valuations Clinical Complexity Biodefense Xenotransplantation | |
SemiconductorsMemory players including SK Hynix, Samsung and Micron are set to become the soul of the new machine. If 50 percent of AI inference moves on-device using flash memory and demand stays high for high-bandwidth memory attached to GPUs, it may upend consensus assumptions of infinite demand for data centers. |
Memory Flash High-bandwidth On-device Inference | |
Rare EarthsChina's near-monopoly over refined rare earths gives it the ultimate chokepoint in geopolitical competition. These metals that the US scarcely processes provide quiet, coercive leverage in the rivalry between America's software supremacy and China's hardware dependency. |
China Monopoly Chokepoint Geopolitical Processing | |
GoldGold is up 45% year-to-date, trading near $4,000 per ounce, outperforming major indices. As volatility rises, capital seeks physical refuge proving that in an age of digital abundance, scarcity still shines literally. |
Refuge Volatility Scarcity Physical Outperforming | |
| 2025 Q2 |
AIAI infrastructure capex surge consuming 5% of U.S. GDP, comparable to 2000 tech boom. Market split between closed models (OpenAI, Anthropic) with high margins but rapid capital burn versus open-source alternatives achieving near-parity performance. Verification and labeled nuance becoming the rate-limiting step for AI progress rather than compute power. |
Infrastructure Capex Models Verification Agents |
RoboticsPhysical Intelligence building foundation model for improvisational robots that can handle unstructured environments. Convergence of AI with physical world creating opportunities to collect real-world robotics datasets and build flexible physical world models that challenge perceptions of robot limitations. |
Physical Intelligence Foundation Models Real-world Data Automation | |
BiotechnologyBiotech pivoting from fixing broken people to upgrading functional ones, with companies like Variant targeting performance enhancers for everyone rather than just patients. Industry shifting from treating sick to optimizing well, despite poor public market performance masking private market opportunities. |
Performance Enhancement Personalized Medicine Longevity Gene Therapy | |
SpaceDeclining payload costs to access space creating convergence opportunities. Impulse Space crafting orbital-transfer vehicles accelerating Mars timelines from decades to months, while Varda's hypersonic re-entry labs collapse orbital experiment cycles from months to days. |
Orbital Transfer Payload Costs Mars Hypersonic | |
DefenseAnduril developing autonomous fighter jets at record speed, while rapidly improving and asymmetrically inexpensive autonomous defense systems create new opportunities. Israel's technological superiority demonstrated through precise decimation of Iranian air defenses with American B-2 stealth bombers. |
Autonomous Systems Fighter Jets Defense Technology Stealth | |
SemiconductorsAI can dream up chip architectures in microseconds but TSMC's fabs run on geological time, with extreme ultraviolet lithography crawling through wafers at the pace of physics. Rate-limited steps hiding in plain sight including rare-earth mining feeding GPU hunger and electric grid constraints. |
TSMC Lithography Rare Earths Manufacturing | |
| 2025 Q1 |
AIArtificial intelligence is transforming human-machine partnerships through flexible interfaces that adapt to human intentions. Engineers now copilot software production alongside coding agents, while cinema directors use AI tools like RunwayML to conjure worlds from thoughts. The evolution from rigid interfaces to conversational AI represents a fundamental shift in how humans and machines collaborate. |
Machine Learning Automation Human-Computer Interface Generative AI Coding Agents |
DefenseDefense technology partnerships are accelerating through collaborative development programs like AUKUS, where Anduril co-designs autonomous submarines with Australia's Royal Navy. The Pentagon's procurement of software and AI, combined with companies like Anduril building AI-powered defense systems, represents a new era of defense innovation driven by startup speed and allied cooperation. |
Autonomous Systems Military Technology Defense Procurement Allied Cooperation Defense AI | |
SpaceSpace commercialization is advancing through collaborative logistics networks, exemplified by Varda's W-series capsule that combines SpaceX rideshares, Rocket Lab guidance, Air Force spectrometers, and NASA heat-shield technology. This integrated approach to space missions demonstrates how partnerships across government and private sectors are enabling new space capabilities. |
Commercial Space Space Manufacturing Satellite Technology Space Logistics Orbital Platforms | |
RoboticsRobotics is evolving from human-controlled tools to collaborative partners through companies like Physical Intelligence building generalized world models and Auris enabling surgical telepresence. The feedback loop between human operators and robotic systems is becoming bidirectional, with robots suggesting trajectories and autonomous systems providing decision support. |
Surgical Robotics Autonomous Systems Telepresence Human-Robot Collaboration Robotic Intelligence | |
BiotechnologyBiotechnology partnerships are creating new models for drug development and genetic research, with companies like Variant Bio sharing upside with African communities providing genetic samples. The sector benefits from collaborative networks that span from university research to pharmaceutical partnerships, creating long-term value chains that extend across decades. |
Genetic Research Drug Development Pharmaceutical Partnerships Precision Medicine Biotech Innovation | |
| 2024 Q4 |
AIAI is democratizing storytelling and augmenting human cognition at scale. The pendulum has swung decisively toward open-source AI models, with companies like Hugging Face and Together AI positioned as dominant leaders. Future AI advantage will come from proprietary data rather than compute power. |
Open Source Foundation Models Proprietary Data Inference Democratization |
DefenseAnduril was selected as one of only two companies for the U.S. Air Force's Collaborative Combat Aircraft program to build autonomous fighter jets. The geopolitical landscape requires technological leadership rooted in democratic values to counter authoritarian regimes. |
Autonomous Systems Military Technology Geopolitical Competition Democratic Values | |
BiotechnologyeGenesis represents breakthrough science in organ transplantation, with only two people currently living with genetically-engineered pig kidney transplants. This demonstrates how biological constraints that existed for centuries are now being overcome through genetic engineering. |
Organ Transplantation Genetic Engineering Medical Breakthrough Biological Compatibility | |
SpaceVarda is one of only three companies globally to have successfully flown a vehicle from space to Earth. This represents advancement in space-to-Earth logistics and manufacturing capabilities. |
Space Manufacturing Reentry Vehicles Space Logistics | |
RoboticsPhysical Intelligence has constructed the largest robotic dataset ever assembled. Lux is funding ventures at the intersection of AI and the 3D physical world, including robotics, manufacturing, and maintenance applications. |
Robotic Datasets Physical AI Manufacturing Automation Maintenance Technology | |
| 2024 Q3 |
AILux views AI as hitting its Menoetius Moment where prideful ignorance of reckless prophets will be revealed. The firm sees infrastructure bottlenecks shifting from chips to power constraints, with future clusters requiring gigawatt-scale power. They believe the future belongs to companies that democratize access through efficiency rather than brute-force computation. |
Infrastructure Efficiency Democratization Clusters Power |
BiotechnologyExemplified by eGenesis investment, Lux focuses on using CRISPR gene editing to make xenotransplantation practical. The company achieved a landmark milestone transplanting a gene-edited porcine kidney into a patient. This represents transforming crisis-driven organ systems to planned, preventative ones while building massive new markets. |
CRISPR Xenotransplantation Gene Therapy Organ Transplant Medical Devices | |
RoboticsLux invests in companies extending human physical capabilities through robotics and AI. From CTRL-Labs translating neuromuscular signals to Physical Intelligence developing modular AI brains for diverse robotic hardware. This represents the evolution from mechanical advantage to sophisticated embodied intelligence. |
Automation Physical Intelligence Embodied Intelligence Neuromuscular Hardware | |
DefenseNational security must be redefined beyond traditional military assets to encompass technological competition. Senate Intelligence Committee chair emphasized that if officers are not AI-enabled, they will lose. Lux continues investing in dual-use technologies serving both commercial and defense applications. |
National Security Dual-use Military Technology Competition AI-enabled | |
SemiconductorsAI infrastructure demands are creating massive physical constraints around chips and power. Current largest AI clusters use 100,000 Nvidia H100 chips consuming 100 megawatts. Next year's clusters will scale to 300,000-500,000 chips requiring nearly a gigawatt of power, highlighting the shift from weightless bits to physical atoms. |
H100 Clusters Power Consumption Infrastructure Scaling | |
| 2024 Q2 |
AILux has early pathbreaking AI investments in Hugging Face, MosaicML, Runway, Together AI, and Modal that are appreciating. The firm views AI as following a hype-hope continuum where short-term disappointment may yield long-term delight. However, many gains will accrue to incumbents like Microsoft, and the rate of growth in AI expectations is slowing. |
Machine Learning Foundation Models AI Infrastructure OpenAI Generative AI |
DefenseLux's aerospace and defense investments emphasize rapid deployment of frontier technologies for multiple domains of warfare. Portfolio includes Anduril, Saildrone, Hadrian, Varda, Epsilon3, and Impulse Space. The firm sees America's sci-tech superiority as demanding versatile vigilance across expanded domains of conflict. |
Aerospace Autonomous Systems Defense Technology Space Military | |
BiotechnologyLux Labs has created over 20 groundbreaking ventures including companies in metabolic disease, neurodegenerative disease, vaccines, and genetic medicines. Recent examples include Eikon with single-molecule tracking technology and Evolutionary Scale with ESM3, a 98-billion-parameter AI model for protein engineering. |
Drug Discovery Protein Engineering Gene Therapy Medical Devices Life Sciences | |
SpaceVarda has built the world's first commercial orbital manufacturing and re-entry capsules, landing the first commercial re-entry capsule on U.S. soil with sci-tech superiority for Mach 15+ flight-testing. It's the only platform that can recover payloads after flights above Mach 6. |
Orbital Manufacturing Space Transportation Satellites Commercial Space Aerospace | |
AutomationHadrian is scaling automated factories of high-precision production machines for defense and aerospace with 20% of the people needed at 5x productivity. Physical Intelligence is building a robotic foundation model that can control multiple robot types for dexterous manipulation tasks using the same model and training code. |
Robotics Manufacturing Industrial Automation Factory Automation Precision Manufacturing | |
| 2023 Q4 |
AILux has devoted exceptional attention to funding robust and open software platforms in artificial intelligence, with portfolio companies like Hugging Face, MosaicML, Runway, Osmo, Together AI and Evolutionary Scale using open approaches to build world-class technology businesses. The firm sees AI as increasingly augmenting burnt-out workers across diverse industries and helping maintain systems through predictive capabilities. |
Open Source Large Language Models Machine Learning Software Platforms Transformers |
DefenseDefense and aerospace is seeing rising investment demand given growing global kinetic conflicts, with leading Lux companies like Anduril, Saildrone, Planet, Impulse Space, Epsilon3 and Nominal winning publicly announced deals of unprecedented size. The firm expects a growing investable universe as standout companies attract talent and capital, turning product launches into programs of record. |
Aerospace Defense Spending Space Government Contracts National Security | |
BiotechnologyBiotech remains an exceptional area for future investment returns, particularly at the intersection with AI, as high interest rates have reset valuations from recent excesses. Lux companies like Eikon, Aera, Cajal, Evolutionary Scale and others are building platforms for rich pipelines of discoveries with rigorous promise for patients, while GLP-1 drugs represent miracle molecules modifying metabolism. |
Drug Discovery GLP1 Therapeutics Clinical Development AI Drug Discovery | |
ResilienceThe firm's central thesis focuses on maintenance of existing systems as entropy accelerates, emphasizing that sustaining effort is the necessary precondition for survival and growth of software code, businesses, machines, human bodies, cities, and civilization itself. Recent headlines of collapsing bridges, derailed trains, and power outages underscore the need for greater investment in maintenance technologies. |
Infrastructure Predictive Maintenance System Reliability Entropy Sustainability |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| No Elevator Pitches found | ||||||||||
| TICKER | COMMENTARY |
|---|
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||
